Literature DB >> 7725744

Classification of papillary cancer of the thyroid based on prognosis.

S Noguchi1, N Murakami, H Kawamoto.   

Abstract

Between 1965 and 1988 there were 2953 patients with papillary carcinoma treated at Noguchi Thyroid Clinic. Among them 761 patients were excluded because the primary tumor was < 10 mm in maximum diameter, the patient's age was > 80, or the patient underwent noncurative surgery. The remaining 2192 patients, 192 men and 2000 women, were analyzed. The mean follow-up period was 12.5 years. Total thyroidectomy, subtotal thyroidectomy, lobectomy with or without isthmectomy, and less than lobectomy were performed in 2.3%, 40.3%, 44.2%, and 13.2%, respectively. Modified radical neck dissection, partial node excision, and no node excision were performed in 77.8%, 6.4%, and 15.8%, respectively. Men and women were separately analyzed because their risk factors and prognosis were significantly different. Multivariate analysis was carried out according to Cox's regression hazard model. Independently significant factors affecting prognosis in men were aged and gross nodal metastasis; and age, gross nodal metastasis, tumor size, and number of adhered tissues or organs were the factors in women. Based on those risk factors patients were classified into three groups. For men, 65.6% were classified in the excellent group and their 10-year survival was 98.4%; 17.2% were classified as intermediate and 17.2% as poor with survival rates of 90.1% and 74.4%, respectively. For female patients 69.6% were classified in the excellent group, 18.6% in the intermediate group, and 11.9% in the poor group with 10-year survivals of 99.3%, 96.4%, and 88.8%, respectively.

Entities:  

Mesh:

Year:  1994        PMID: 7725744     DOI: 10.1007/bf00353763

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  39 in total

1.  Current results of conservative surgery for differentiated thyroid carcinoma.

Authors:  R L Rossi; B Cady; M L Silverman; M S Wool; T A Horner
Journal:  World J Surg       Date:  1986-08       Impact factor: 3.352

2.  Selection of surgical treatment for well differentiated thyroid carcinomas.

Authors:  J A Buckwalter; C G Thomas
Journal:  Ann Surg       Date:  1972-10       Impact factor: 12.969

3.  Papillary carcinoma of the thyroid. II. Value of prophylactic lymph node excision.

Authors:  S Noguchi; A Noguchi; N Murakami
Journal:  Cancer       Date:  1970-11       Impact factor: 6.860

4.  Papillary carcinoma of the thyroid. I. Developing pattern of metastasis.

Authors:  S Noguchi; A Noguchi; N Murakami
Journal:  Cancer       Date:  1970-11       Impact factor: 6.860

Review 5.  The value of lymph-node dissection in patients with differentiated thyroid cancer.

Authors:  S Noguchi; N Murakami
Journal:  Surg Clin North Am       Date:  1987-04       Impact factor: 2.741

6.  Treatment of intrathyroidal papillary carcinoma of the thyroid.

Authors:  A L Vickery; C A Wang; A M Walker
Journal:  Cancer       Date:  1987-12-01       Impact factor: 6.860

7.  Background mortality in clinical survival studies.

Authors:  H A Verheul; E Dekker; P Bossuyt; A C Moulijn; A J Dunning
Journal:  Lancet       Date:  1993-04-03       Impact factor: 79.321

8.  Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases.

Authors:  N A Samaan; Y K Maheshwari; S Nader; C S Hill; P N Schultz; T P Haynie; R C Hickey; R L Clark; H Goepfert; M L Ibanez; C E Litton
Journal:  J Clin Endocrinol Metab       Date:  1983-06       Impact factor: 5.958

9.  Risk factor analysis in differentiated thyroid cancer.

Authors:  B Cady; C E Sedgwick; W A Meissner; M S Wool; F A Salzman; J Werber
Journal:  Cancer       Date:  1979-03       Impact factor: 6.860

10.  Significance of lymph node metastasis in differentiated thyroid cancer.

Authors:  J Harwood; O H Clark; J E Dunphy
Journal:  Am J Surg       Date:  1978-07       Impact factor: 2.565

View more
  22 in total

1.  A novel definition of extrathyroidal invasion for patients with papillary thyroid carcinoma for predicting prognosis.

Authors:  Muneki Hotomi; Iwao Sugitani; Kazuhisa Toda; Kazuyoshi Kawabata; Yoshihide Fujimoto
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

2.  Validation of the QTNM staging system for cancer-specific survival in patients with differentiated thyroid cancer.

Authors:  Daniel Mankarios; Peter Baade; Pip Youl; Robin H Mortimer; Adedayo A Onitilo; Anthony Russell; Suhail A R Doi
Journal:  Endocrine       Date:  2013-10-31       Impact factor: 3.633

3.  Thyroid cancer associated with adenomatous goiter: an analysis of the incidence and clinical factors.

Authors:  H Yamashita; S Noguchi; S Watanabe; S Uchino; H Kawamoto; M Toda; N Murakami; I Nakayama; H Yamashita
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

4.  Usefulness of endoscopic ultrasonography (EUS) in diagnosing esophageal infiltration of thyroid cancer.

Authors:  A Ohshima; H Yamashita; S Noguchi; S Uchino; S Watanabe; M Toda; H Yamashita; E Koike; K Takatsu; M Inomata; T Arita
Journal:  J Endocrinol Invest       Date:  2001-09       Impact factor: 4.256

5.  Lymphocyte-to-monocyte ratio prior to radioiodine ablation in low- and intermediate-risk, papillary thyroid cancer.

Authors:  Keunyoung Kim; Kyoungjune Pak; In-Joo Kim; Mijin Kim; Bo Hyun Kim; Byung-Joo Lee; Seong-Jang Kim
Journal:  Endocrine       Date:  2020-05-05       Impact factor: 3.633

6.  Placement of self-expandable metallic stents for tracheal stenosis secondary to thyroid cancer.

Authors:  Rena Yuasa; Yoshinobu Hata; Hajime Otsuka; Takashi Makino; Satoshi Koezuka; Fumitomo Sato; Kazuyoshi Tamaki; Shuichi Sasamoto; Keigo Takagi; Akira Iyoda
Journal:  Mol Clin Oncol       Date:  2014-07-17

Review 7.  Management of low-risk papillary thyroid carcinoma: unique conventional policy in Japan and our efforts to improve the level of evidence.

Authors:  Iwao Sugitani; Yoshihide Fujimoto
Journal:  Surg Today       Date:  2010-02-24       Impact factor: 2.549

8.  Characteristics and prognostic factors in patients with differentiated thyroid cancer who underwent a total or subtotal thyroidectomy: surgical approach for high-risk patients.

Authors:  T Kobayashi; H Asakawa; Y Komoike; Y Tamaki; M Monden
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

9.  Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma.

Authors:  Jack M Monchik; Gianluca Donatini; Jason Iannuccilli; Damian E Dupuy
Journal:  Ann Surg       Date:  2006-08       Impact factor: 12.969

10.  Staging systems for papillary thyroid carcinoma: a study of 2 tertiary referral centers.

Authors:  Brian Hung-Hin Lang; Sin-Ming Chow; Chung-Yau Lo; Stephen C K Law; King-Yin Lam
Journal:  Ann Surg       Date:  2007-07       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.